{"organizations": [], "uuid": "f13be45631e69fad4dc524978464191e7a271106", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.tmcnet.com", "main_image": "", "site_section": "http://rss.tmcnet.com/rss/information%20technology", "section_title": "TMCnet.com RSS Service: information technology", "url": "http://www.tmcnet.com/usubmit/2015/10/19/8263417.htm", "country": "US", "title": "Aetna Announces Shareholder Approval in Connection with Proposed Humana Acquisition", "performance_score": 0, "site": "tmcnet.com", "participants_count": 0, "title_full": "Aetna Announces Shareholder Approval in Connection with Proposed Humana Acquisition", "spam_score": 0.0, "site_type": "news", "published": "2015-10-19T22:01:00.000+03:00", "replies_count": 0, "uuid": "f13be45631e69fad4dc524978464191e7a271106"}, "author": "", "url": "http://www.tmcnet.com/usubmit/2015/10/19/8263417.htm", "ord_in_thread": 0, "title": "Aetna Announces Shareholder Approval in Connection with Proposed Humana Acquisition", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Aetna Announces Shareholder Approval in Connection with Proposed Humana Acquisition [October 19, 2015] Tweet \nAetna (NYSE: AET) announced that, at a special meeting of shareholders today, its shareholders voted to approve the issuance of Aetna common shares to Humana stockholders in connection with Aetna's proposed acquisition of Humana. Of the 287,661,869 shares voting at today's special meeting of shareholders, 99 percent voted in favor of the issuance of the Aetna common shares. The Aetna common shares will be issued under and in accordance with the agreement and plan of merger dated as of July 2, 2015, relating to the proposed acquisition. \nThe completion of the Humana transaction remains subject to customary closing conditions, including the approval by Humana stockholders of the agreement and plan of merger, as well as the expiration of the federal Hart-Scott-Rodino antitrust waiting period and approvals of state departments of insurance and other regulators. Aetna continues to expect that the transaction will be completed in the second half of 2016. \nAbout Aetna \nAetna is one of the nation's leading diversified health care benefits companies, serving an estimated 46.7 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com and learn about how Aetna is helping to build a healthier world . @AetnaNews \nImportant Information For Investors And Stockholders \nThis communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction between Aetna Inc. (\"Aetna\") and Humana Inc. (\"Humana\"), Aetna has filed with the Securities and Exchange Commission (the \"SEC ( News - Alert )\") a registration statement on Form S-4, including Amendment No. 1 thereto, containing a joint proxy statement of Aetna and Humana that also constitutes a prospectus of Aetna. The registration statemet was declared effective by the SEC on August 28, 2015, and Aetna and Humana commenced mailing the definitive joint proxy statement/prospectus to shareholders of Aetna and stockholders of Humana on or about September 1, 2015. INVESTORS AND SECURITY HOLDERS OF AETNA AND HUMANA ARE URGED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of the registration statement and the definitive joint proxy statement/prospectus and other documents filed with the SEC by Aetna or Humana through the website maintained by the SEC at http://www.sec.gov . Copies of the documents filed with the SEC by Aetna are available free of charge on Aetna's internet website at http://www.Aetna.com or by contacting Aetna's Investor Relations Department at 860-273-2402. Copies of the documents filed with the SEC by Humana are available free of charge on Humana's internet website at http://www.Humana.com or by contacting Humana's Investor Relations Department at 502-580-3622. \nAetna, Humana, their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Humana is set forth in its Annual Report on Form 10-K for the year ended December 31, 2014, which was filed with the SEC on February 18, 2015, its proxy statement for its 2015 annual meeting of stockholders, which was filed with the SEC on March 6, 2015, and its Current Report on Form 8-K, which was filed with the SEC on April 17, 2015. Information about the directors and executive officers of Aetna is set forth in its Annual Report on Form 10-K for the year ended December 31, 2014 (\"Aetna's Annual Report\"), which was filed with the SEC on February 27, 2015, its proxy statement for its 2015 annual meeting of shareholders, which was filed with the SEC on April 3, 2015 and its Current Reports on Form 8-K, which were filed with the SEC on May 19, 2015, May 26, 2015, July 2, 2015, September 30, 2015 and the Form 8-K/A amending the September 30, 2015 Form 8-K filed on October 7, 2015. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the definitive joint proxy statement/prospectus of Aetna and Humana filed with the SEC and other relevant materials to be filed with the SEC when they become available. \nCautionary Statement Regarding Forward-Looking Statements \nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the use of forward-looking terminology such as \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"explore,\" \"evaluate,\" \"intend,\" \"may,\" \"might,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"seek,\" \"should,\" or \"will,\" or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond Aetna's and Humana's control. \nStatements in this press release that are forward-looking, including the projected date the proposed acquisition will be completed, are based on management's estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of which are beyond Aetna's and Humana's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by Aetna's management, including, but not limited to: the risk that a condition to closing of the proposed acquisition may not be satisfied; the risk that a regulatory approval that may be required for the proposed acquisition is delayed, is not obtained or is obtained subject to conditions that are not anticipated; and the outcome of various litigation matters related to the proposed acquisition. Other important risk factors include: a downgrade in Aetna's financial ratings; and adverse impacts from any failure to raise the U.S. Federal government's debt ceiling or any sustained U.S. Federal government shut down. For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2014 Annual Report on Form 10-K (\"Aetna's 2014 Annual Report\") on file with the Securities and Exchange Commission (\"SEC\"). You should also read Aetna's 2014 Annual Report and Aetna's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015, on file with the SEC, for a discussion of Aetna's historical results of operations and financial condition. \nNo assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do occur, what impact they will have on the results of operations, financial condition or cash flows of Aetna or Humana. Neither Aetna nor Humana assumes any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date. View source version on businesswire.com: http://www.businesswire.com/news/home/20151019006447/en/", "external_links": [], "published": "2015-10-19T22:01:00.000+03:00", "crawled": "2015-10-20T04:27:11.038+03:00", "highlightTitle": ""}